These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24379208)

  • 1. Cytomegalovirus mutants resistant to ganciclovir and cidofovir differ in susceptibilities to synguanol and its 6-ether and 6-thioether derivatives.
    Chou S; Komazin-Meredith G; Williams JD; Bowlin TL
    Antimicrob Agents Chemother; 2014; 58(3):1809-12. PubMed ID: 24379208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclopropavir susceptibility of cytomegalovirus DNA polymerase mutants selected after antiviral drug exposure.
    Chou S; Marousek G; Bowlin TL
    Antimicrob Agents Chemother; 2012 Jan; 56(1):197-201. PubMed ID: 21968367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and characterization of a GCV resistant HCMV UL97-mutation and a drug sensitive UL54-mutation.
    Fischer L; Laib Sampaio K; Jahn G; Hamprecht K; Göhring K
    Antiviral Res; 2013 Dec; 100(3):575-7. PubMed ID: 24120366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymporphism with impact on phenotypic drug-resistance.
    Fischer L; Imrich E; Sampaio KL; Hofmann J; Jahn G; Hamprecht K; Göhring K
    Antiviral Res; 2016 Jul; 131():1-8. PubMed ID: 27058773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet.
    Drew WL; Miner RC; Marousek GI; Chou S
    J Clin Virol; 2006 Oct; 37(2):124-7. PubMed ID: 16962820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Z-isomers of 2-hydroxymethylcyclopropylidenemethyl adenine (synadenol) and guanine (synguanol) are active against ganciclovir- and foscarnet-resistant human cytomegalovirus UL97 mutants.
    Baldanti F; Sarasini A; Drach JC; Zemlicka J; Gerna G
    Antiviral Res; 2002 Dec; 56(3):273-8. PubMed ID: 12406510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes.
    Smith IL; Cherrington JM; Jiles RE; Fuller MD; Freeman WR; Spector SA
    J Infect Dis; 1997 Jul; 176(1):69-77. PubMed ID: 9207351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Cytomegalovirus UL54 DNA Polymerase Gene Mutations Selected In Vitro That Confer Brincidofovir Resistance.
    Chou S; Ercolani RJ; Lanier ER
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3845-8. PubMed ID: 27044553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus.
    James SH; Price NB; Hartline CB; Lanier ER; Prichard MN
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3321-5. PubMed ID: 23650158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of current and novel antivirals in combination against human cytomegalovirus.
    O'Brien MS; Markovich KC; Selleseth D; DeVita AV; Sethna P; Gentry BG
    Antiviral Res; 2018 Oct; 158():255-263. PubMed ID: 30153445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of newly detected, drug-related HCMV UL97- and UL54-mutations using a modified plaque reduction assay.
    Fischer L; Sampaio KL; Jahn G; Hamprecht K; Göhring K
    J Clin Virol; 2015 Aug; 69():150-5. PubMed ID: 26209398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in understanding cytomegalovirus drug resistance.
    Emery VC
    J Clin Virol; 2001 Jun; 21(3):223-8. PubMed ID: 11397658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.
    Oshima K; Kanda Y; Kako S; Asano-Mori Y; Watanabe T; Motokura T; Chiba S; Shiraki K; Kurokawa M
    J Med Virol; 2008 Oct; 80(10):1769-75. PubMed ID: 18712833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility.
    Chou S; Bowlin TL
    Antimicrob Agents Chemother; 2011 Jan; 55(1):382-4. PubMed ID: 21041510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated evolution of maribavir resistance in a cytomegalovirus exonuclease domain II mutant.
    Chou S; Marousek GI
    J Virol; 2008 Jan; 82(1):246-53. PubMed ID: 17942550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New reporter cell line to evaluate the sequential emergence of multiple human cytomegalovirus mutations during in vitro drug exposure.
    Gilbert C; Boivin G
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4860-6. PubMed ID: 16304146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cytomegalovirus UL97 kinase is involved in the mechanism of action of methylenecyclopropane analogs with 6-ether and -thioether substitutions.
    Komazin-Meredith G; Chou S; Prichard MN; Hartline CB; Cardinale SC; Comeau K; Williams JD; Khan AR; Peet NP; Bowlin TL
    Antimicrob Agents Chemother; 2014; 58(1):274-8. PubMed ID: 24145545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
    Smee DF; Barnett BB; Sidwell RW; Reist EJ; Holy A
    Antiviral Res; 1995 Jan; 26(1):1-9. PubMed ID: 7741517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirus.
    Scott GM; Ng HL; Morton CJ; Parker MW; Rawlinson WD
    J Gen Virol; 2005 Aug; 86(Pt 8):2141-2151. PubMed ID: 16033961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments.
    Cihlar T; Fuller MD; Cherrington JM
    J Virol; 1998 Jul; 72(7):5927-36. PubMed ID: 9621055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.